Newron Pharmaceuticals S.p.A. | WebDisclosure

Basculer en Français

8396	Companies
122097	Keywords
60577	Articles
65553	Press releases

Headlines Articles Press releases Newron Pharmaceuticals S.p.A.

Home
Companies
Newron Pharmaceuticals S.p.A.

BRIEF

published on 12/13/2024 at 07:05, 8 days 12 hours ago

Newron et EA Pharma signent un accord de licence pour Evenamide en Asie

Evenamide Traitement De La Schizophrénie Contrat De Licence Newron Pharmaceutique EA Pharma
BRIEF

published on 12/13/2024 at 07:05, 8 days 12 hours ago

Newron and EA Pharma Sign License Agreement for Evenamide in Asia

Newron Pharmaceuticals Evenamide Schizophrenia Treatment License Agreement EA Pharma
PRESS RELEASE

published on 12/13/2024 at 07:00, 8 days 12 hours ago

Newron and EA Pharma (a subsidiary of Eisai Co., Ltd.) announce license agreement for evenamide in Japan and other Asian territories
Newron Pharmaceuticals S.p.A. and EA Pharma (a subsidiary of Eisai Co., Ltd.) have signed a license agreement for evenamide in Japan and other Asian territories, aiming to address unmet medical needs in patients with schizophrenia

Schizophrenia Newron Pharmaceuticals Evenamide License Agreement EA Pharma
BRIEF

published on 09/19/2024 at 07:05, 3 months 2 days ago

Newron Pharmaceuticals présente ses résultats du premier semestre 2024 et son point sur ses activités

Essais Cliniques Evenamide Traitement De La Schizophrénie Premier Semestre 2024 Newron Pharmaceutique
BRIEF

published on 09/19/2024 at 07:05, 3 months 2 days ago

Newron Pharmaceuticals Presents H1 2024 Results and Business Update

Clinical Trials Newron Pharmaceuticals Evenamide Schizophrenia Treatment H1 2024
PRESS RELEASE

published on 09/19/2024 at 07:00, 3 months 2 days ago

Newron presents H1 2024 results and provides business update
Newron Pharmaceuticals presents H1 2024 financial results and operational highlights, focusing on evenamide studies for schizophrenia treatment and corporate developments

Financial Results Newron Pharmaceuticals Evenamide Schizophrenia Treatment H1 2024
BRIEF

published on 06/25/2024 at 17:50, 5 months 26 days ago

Newron Pharmaceuticals souligne la journée des investisseurs 2024 à New York

Essais Cliniques Schizophrénie Produits Pharmaceutiques Newron Evenamide Journée Des Investisseurs
BRIEF

published on 06/25/2024 at 17:50, 5 months 26 days ago

Newron Pharmaceuticals Highlights 2024 Investor Day in NYC

Investor Day Clinical Trials Schizophrenia Newron Pharmaceuticals Evenamide
PRESS RELEASE

published on 06/25/2024 at 17:45, 5 months 26 days ago

Newron Pharmaceuticals reports on its 2024 Investor Day in New York City
Newron Pharmaceuticals reports on its 2024 Investor Day in New York City, highlighting evenamide's potential in treating treatment-resistant schizophrenia. Leading experts present clinical data and benefits of evenamide

Clinical Data Schizophrenia 2024 Investor Day Newron Pharmaceuticals Evenamide
BRIEF

published on 06/18/2024 at 17:50, 6 months 3 days ago

Journée des investisseurs 2024 de Newron Pharmaceuticals, le 25 juin 2024, à New York

Schizophrénie Produits Pharmaceutiques Newron Evenamide Recherche Clinique Journée Des Investisseurs

1 2 ... 5

Accesswire

Published on 12/21/2024 at 01:30, 17 hours 46 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 46 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 11 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours 16 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 46 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

EQS Group

Published on 12/21/2024 at 00:51, 18 hours 25 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 31 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

Les Echos

Published on 12/21/2024 at 12:17, 6 hours 58 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 6 hours 58 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE